Common Contracts
1 similar Study Agreement contracts
CLINICAL STUDY AGREEMENT PROTOCOL: DAL-301 SITE: 18-110PRINCIPAL INVESTIGATOR: XXXXXXX DALCOR PHARMA UK LTD 05- DEC- 2016 VERSION: 1 . 0 COUNTRY: CZECH REPUBLIC SMLOUVA O KLINICKÉ STUDII PROTOKOL: DAL-301 CENTRUM: 18-110HLAVNÍ ZKOUŠEJÍCÍ: XXXXXXX...Study Agreement • November 5th, 2020
CLINICAL STUDY AGREEMENTThis clinical study agreement (“Agreement”), effective as of the day of publication in the contracts registry, was entered into by and between Medpace, Inc., with its principal office and place of business at 5375 Medpace Way, Cincinnati, Ohio 45227, USA ("Medpace”); and Fakultní nemocnice v Motole, the State budgetary organization, represented by XXXXXXX, based on Authorization dated 29 November 2016, with its principal office at V Uvalu 84, 150 06 Praha 5, Czech Republic (the “Health Services Provider”). Medpace and the Health Services Provider are sometimes collectively referred to herein as parties (the “Parties”). WHEREAS, DalCor Pharma UK Ltd, Registered office address at 3rd Floor 1 Ashley Road, Altrincham, Cheshire, United Kingdom, WA14 2DT, Company number 09429551 (“Sponsor”) is sponsoring a clinical study on the compound Dalcetrapib (the “Study Drug”), in accordance with Protocol No. DAL-301, titled “A phase III, double- blind, randomized placebo-contr
